Cargando…
In Vivo Murine-Matured Human CD3(+) Cells as a Preclinical Model for T Cell-Based Immunotherapies
Adoptive cellular immunotherapy is a promising and powerful method for the treatment of a broad range of malignant and infectious diseases. Although the concept of cellular immunotherapy was originally proposed in the 1990s, it has not seen successful clinical application until recent years. Despite...
Autores principales: | Haworth, Kevin G., Ironside, Christina, Norgaard, Zachary K., Obenza, Willimark M., Adair, Jennifer E., Kiem, Hans-Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5470556/ https://www.ncbi.nlm.nih.gov/pubmed/28649577 http://dx.doi.org/10.1016/j.omtm.2017.05.004 |
Ejemplares similares
-
In vivo Selection of Autologous MGMT Gene-Modified Cells Following Reduced Intensity Conditioning with BCNU and Temozolomide in the Dog Model
por: Gori, Jennifer L., et al.
Publicado: (2012) -
Stem Cell Selection In Vivo Using Foamy Vectors Cures Canine Pyruvate Kinase Deficiency
por: Trobridge, Grant D., et al.
Publicado: (2012) -
Correction: Stem Cell Selection In Vivo Using Foamy Vectors Cures Canine Pyruvate Kinase Deficiency
por: Trobridge, Grant D., et al.
Publicado: (2013) -
Safe and Effective Gene Therapy for Murine Wiskott-Aldrich Syndrome Using an Insulated Lentiviral Vector
por: Singh, Swati, et al.
Publicado: (2016) -
Preclinical evaluation of anti-CD38 therapy in mature T-cell neoplasms
por: Isabelle, Colleen, et al.
Publicado: (2023)